PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway

The Peroxisome Proliferator-Activated Receptor   Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin

(2014) T. Aprahamian et al.   JOURNAL OF IMMUNOLOGY

Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus

(2009) Marcia Venegas-Pont et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

MoMa from patients with systemic lupus erythematosus show altered adhesive activity

(2009) Luis E. Muñoz et al.   AUTOIMMUNITY

Why can't we find a new treatment for SLE?

(2009) Robert Eisenberg   JOURNAL OF AUTOIMMUNITY

The Peroxisome Proliferator-Activated Receptor   Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus

(2009) W. Zhao et al.   JOURNAL OF IMMUNOLOGY

Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm

(2009) Kenneth R. Feingold et al.   JOURNAL OF LIPID RESEARCH

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

(2009) Christina G. Katsiari et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE)

(2008) C. Janko et al.   AUTOIMMUNITY REVIEWS

Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines

(2008) Christine Guo et al.   CIRCULATION

Angiotensin II modulates CD40 expression in vascular smooth muscle cells

(2008) Heraldo P. Souza et al.   CLINICAL SCIENCE

Peroxisome Proliferator-Activated Receptor-γ1 Gene Therapy Attenuates Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

(2008) Qin Hu et al.   HUMAN GENE THERAPY

Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages

(2008) Brian M. Necela et al.   IMMUNOLOGY

CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression

(2008) Alexander Michael Dohnal et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation

(2007) M.P. Khanolkar et al.   ATHEROSCLEROSIS